Recent Finacing
Recent Raise
Delve Bio provides a pathogen-agnostic metagenomic NGS platform and computational pipeline that analyzes all nucleic acids in patient samples to identify bacteria, fungi, parasites, viruses, host response and resistance
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Delve Bio.
